Insider · CIK 0001744627

Burgess Paul D.

Reports to the SEC for 3 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001744627

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-16	KLRAKailera Therapeutics, Inc. · Stock Option (right to buy)A Award	See Remarks	AAward	+100K sh	—	—	100,000
2026-04-16	KLRAKailera Therapeutics, Inc. · Stock Option (right to buy)A Award	See Remarks	AAward	+100K sh	—	—	100,000
2024-08-01	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsD Disposition to Issuer	See Remarks	DDisposition to Issuer	−81.1K sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−95.9K sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−45.7K sh	—	—	0
2024-01-19	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsA Award	See Remarks	AAward	+81.1K sh	—	—	81,065
2023-12-19	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+23.8K sh	—	—	45,727
2023-12-19	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−23.8K sh	—	—	0
2023-08-04	Cerevel Therapeutics Holdings, Inc.P Purchase	See Remarks	PPurchase	+21.9K sh	$22.93	+$502K	21,880
2023-07-03	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+95.9K sh	—	—	95,931
2023-07-03	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsA Award	See Remarks	AAward	+23.8K sh	—	—	23,847
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Chief Operating Officer, CLO, Secretary	SSale	−90K sh	—	—	0
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Chief Operating Officer, CLO, Secretary	SSale	−70K sh	—	—	0
2021-09-14	Translate Bio, Inc.S Sale	Chief Operating Officer, CLO, Secretary	SSale	−71.8K sh	$38.00	−$2.73M	0
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Chief Operating Officer, CLO, Secretary	SSale	−220K sh	—	—	0
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Chief Operating Officer, CLO, Secretary	SSale	−150K sh	—	—	0
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Chief Operating Officer, CLO, Secretary	SSale	−150K sh	—	—	0
2021-03-09	Translate Bio, Inc.Stock Option (right to buy)A Award	Chief Operating Officer, CLO, Secretary	AAward	+90K sh	—	—	90,000
2020-03-03	Translate Bio, Inc.Stock Option (right to buy)A Award	Chief Operating Officer, CLO, Secretary	AAward	+150K sh	—	—	150,000
2019-03-08	Translate Bio, Inc.Stock Option (right to buy)A Award	Chief Operating Officer, CLO, Secretary	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
Apr 204
Burgess Paul D.0001193125-26-164275
SEC(opens sec.gov)
Aug 54
Burgess Paul D.0000950170-24-090787
SEC(opens sec.gov)
Jan 234
Burgess Paul D.0000950170-24-006677
SEC(opens sec.gov)
Dec 214
Burgess Paul D.0000950170-23-072380
SEC(opens sec.gov)
Aug 74
Burgess Paul D.0000950170-23-039165
SEC(opens sec.gov)
Jul 64
Burgess Paul D.0000950170-23-032016
SEC(opens sec.gov)
Sep 144
Burgess Paul D.0001209191-21-056057
SEC(opens sec.gov)
Mar 94
Burgess Paul D.0001209191-21-019299
SEC(opens sec.gov)
Mar 54
Burgess Paul D.0001209191-20-016799
SEC(opens sec.gov)
Mar 124
Burgess Paul D.0001209191-19-018950
SEC(opens sec.gov)

Companies

Address

C/O KAILERA THERAPEUTICS, INC. 180 THIRD AVENUE, 4TH FLOOR

WALTHAM, MA, 02451